05 Mar, 2025
This article is medically reviewed by Dr. Abhishek Dudhatra, Consultant - Hemato Oncology, HCG Aastha Cancer Centre, Ahmedabad.
Leukemia and lymphoma refer to the two different types of blood cancer. The difference between leukemia and lymphoma is that leukemia primarily impacts the bone marrow and causes the overproduction of abnormal white cells. Lymphoma, on the other hand, starts in the lymphatic system, causing abnormal cell clusters, forming primarily within lymph nodes and other lymphatic tissues.
In this article, let’s understand the whole dynamics of leukemia vs. lymphoma.
Leukemia is a cancer of the blood cells. It is a type of blood cancer that affects the blood and bone marrow and causes the production of abnormal white blood cells. These white cells increase infection and replace healthy blood cells.
The type of leukemia depends on the type of blood cell that becomes cancer and its growth rate. The most common types of leukemia are:
Acute Lymphocytic Leukemia (ALL) is a type of leukemia that progresses rapidly and replaces healthy cells.
Acute myeloid leukemia (AML) is another type of leukemia, which is a fast-growing cancer of the blood and bone marrow.
Chronic Lymphocytic Leukemia (CLL) originates in lymphocytes in the bone marrow and grows into the blood. This cancer type progresses slowly and sometimes takes years to present symptoms.
Chronic Myeloid Leukemia (CML) is a type of leukemia that starts in the blood-forming cells of the bone marrow and gradually spreads to the bloodstream.
Common symptoms of leukemia are:
Leukemia diagnosis is generally done through a combination of medical history, physical exams, and several tests. Common diagnostic methods include:
The causes of leukemia are not widely understood, but it has been reported that several key factors can increase the risk of developing it.
Some of the key risk factors for leukemia are:
Lymphoma is a blood cancer that affects lymphocytes, which are a type of white blood cell. It arises when a DNA mutation causes lymphocytes to grow abnormally and spread through the blood and lymphatic system. Lymphoma affects areas like lymph nodes, spleen, and bone marrow.
Lymphomas are broadly categorized into two groups:
1. Non-Hodgkin’s Lymphoma: The most common type of lymphoma is non-Hodgkin’s lymphoma, and it develops in the lymphatic system. It tends to develop faster in older adults. It has about 70 subtypes.
2. Hodgkin’s Lymphoma: Hodgkin’s lymphoma develops in a type of B-cell that is found in the bone marrow.
Symptoms of lymphoma are:
The diagnosis of lymphoma usually starts with a detailed physical exam, during which the doctor looks for swollen lymph nodes in the neck, underarms, and groin. If the observations from these tests are concerning, additional tests will be recommended.
The exact cause of lymphoma is unknown, but some risk factors are:
Although both leukemia and lymphoma are classified as blood cancers, they differ in various aspects.
Understanding leukemia and lymphoma differences is crucial for diagnosis and treatment. The lymphoma vs. leukemia difference lies in the following factors:
Leukemia | Lymphoma | |
---|---|---|
Origin | Leukemia develops in bone marrow. | Lymphoma originates in lymph nodes or the spleen. |
Symptoms | Leukemia may cause pale skin, petechiae (small red spots), bone pain, and easy bruising or bleeding. | Lymphoma is often characterized by swollen lymph nodes, night sweats, coughing, shortness of breath, and itchy skin. |
Diagnostics | Leukemia is typically diagnosed with a complete blood count (CBC) test, and its specific type is confirmed through a bone marrow biopsy. | Diagnosing lymphoma usually requires a biopsy of a lymph node or bone marrow, along with imaging tests to determine the cancer’s stage. |
Treatments | Treatment options for leukemia include chemotherapy, radiation therapy, and bone marrow or stem cell transplants. Additionally, monoclonal antibody therapy may be recommended for leukemia. |
Lymphoma treatment options include chemotherapy, radiation therapy, and bone marrow or stem cell transplants. Additional treatments for lymphoma may include immunotherapy, radioimmunotherapy, photopheresis, and phototherapy. |
The prognosis and survival rates for leukemia and lymphoma depend on factors like type and stage of cancer, the patient’s age and overall health, and the response to treatment.
Survival rates for leukemia vary by type, with around 50–80% of people surviving at least five years. ALL has an 80% survival rate and is considered the highest.
Hodgkin’s lymphoma has a prognosis of survival rate of around 85%. Non-Hodgkin’s lymphoma (NHL) has a more varied prognosis, with a five-year survival rate of about 72%.
For both leukemia and lymphoma, the prognosis depends on various factors.
Treatments for leukemia and lymphoma vary depending on the type and stage of cancer.
Commonly recommended treatments for leukemia include:
Commonly recommended treatments for lymphoma include:
Both leukemia and lymphoma are blood cancers but differentiate in origin, symptoms, and treatment. Leukemia develops in the bone marrow and spreads through the bloodstream, while lymphoma originates in the lymphatic system.
Dr. Abhishek Dudhatra
Consultant - Hemato Oncology
MBBS, MD (Medicine), DNB (Haematology), Fellowship-BMT (NUH, Singapore)
Dr. Abhishek is an acclaimed oncologist who specializes in hematology and hemato-oncology, along with a special interest in bone marrow transplantation. He is available for consultations at HCG Aastha Cancer Centre, a leading hospital for cancer treatment in Ahmedabad. He has completed his fellowship training in hematopoietic stem cell transplantation from the prestigious National University Hospital, Singapore. His expertise has been duly recognized by the gold medal he was awarded for the DNB hematology examination in 2014-2015 and served as a reviewer for the prestigious journal “Bone Marrow Transplantation.”
To book an appointment with Dr. Abhishek Dudhatra, please click here.